O’charoenrat et al. showed that target therapy by MMP inhibitors blocking EGF receptors successfully inhibited tumor progression in head and neck squamous cell carcinomas (O-Charoenrat et al., 2002), but in this study, HER-2 and MMPs did not have a meaningful relationship. Here, ERBB2 is linked to neoplasm.